指南与共识胸部肿瘤

国际胸腺恶性肿瘤兴趣组(ITMIG)医师的胸腺癌管理模式及胸腺癌工作组共识

Thymic Carcinoma Management Patterns among International Thymic Malignancy Interest Group (ITMIG) Physicians with Consensus from the Thymic Carcinoma Working Group.
指南 / 共识 · J Thorac Oncol · 2016-11-19

该研究对100名ITMIG成员进行16题电子调查,以了解胸腺癌临床实践的一致性与变异性,并与胸腺癌工作组讨论争议领域达成共识。结果显示,对于体能状态良好、晚期但可切除的患者,多学科治疗联合根治性手术获得普遍认同;而术前组织学确认的必要性、辅助治疗的作用、最佳一线化疗方案及边缘可切除(侵犯大血管、心包和肺)的推荐治疗疗程存在争议。

要点

  • 100名ITMIG成员参与调查,部分领域有共识但临床实践差异显著。
  • 体能状态良好、晚期但可切除患者的多学科治疗联合根治性手术获普遍认同。
  • 术前组织学确认、辅助治疗、最佳一线化疗及边缘可切除疗程存在争议。

核心结论

  • 调查结果描述了100名对胸腺恶性肿瘤有特定兴趣或专长的ITMIG成员对胸腺癌的管理模式;尽管某些方面存在共识,但临床实践似乎差异显著。
  • 亟需协作研究以确定最佳评估和治疗策略;鉴于许多病例需要多学科治疗,对胸腺癌患者管理进行多学科讨论至关重要。

研究设计与样本

  • 对国际胸腺恶性肿瘤兴趣组(ITMIG)成员进行16题电子调查,并与胸腺癌工作组讨论争议领域以达成共识。

主要发现

  • 共100名ITMIG成员回复调查。
  • 对于体能状态良好、晚期但可切除的患者,多学科治疗联合根治性手术的作用获得普遍认同。
  • 争议领域包括术前组织学确认的必要性、辅助治疗的作用、最佳一线化疗方案以及侵犯大血管、心包和肺的边缘可切除疾病的推荐治疗疗程。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Thymic carcinomas are rare epithelial malignancies with limited data to guide management. METHODS: To identify areas of agreement and variability in current clinical practice, a 16-question electronic survey was given to members of the International Thymic Malignancy Interest Group (ITMIG). Areas of controversy were discussed with the Thymic Carcinoma Working Group and consensus was achieved, as described. RESULTS: A total of 100 ITMIG members responded. There was general agreement regarding the role for multimodality therapy with definitive surgical resection in physically fit patients with advanced but resectable disease. Areas of controversy included the need for histologic confirmation before surgery, the role of adjuvant therapy, the optimal first-line chemotherapy regimen, and the recommended treatment course for marginally resectable disease with invasion into the great vessels, pericardium, and lungs. CONCLUSIONS: The results of the questionnaire provide a description of the management of thymic carcinoma by 100 ITMIG members with a specific interest or expertise in thymic malignancies. Although there was agreement in some areas, clinical practice appears to vary significantly. There is a great need for collaborative research to identify optimal evaluation and treatment strategies. Given the need for multimodality therapy in many cases, a multidisciplinary discussion of the management of patients with thymic carcinoma is critical.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Shepherd A, Riely G, Detterbeck F, et al. Thymic Carcinoma Management Patterns among International Thymic Malignancy Interest Group (ITMIG) Physicians with Consensus from the Thymic Carcinoma Working Group. J Thorac Oncol. 2016. PMID: 27876674. doi:10.1016/j.jtho.2016.11.2219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。